A citation-based method for searching scientific literature

Jen-Chieh Lee, Yung-Ming Jeng, Jau-Yu Liau, Jia-Huei Tsai, Hung-Han Hsu, Ching-Yao Yang. Mod Pathol 2015
Times Cited: 34







List of co-cited articles
373 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
700
61

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
318
52

Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome.
Jau-Yu Liau, Jia-Huei Tsai, Yung-Ming Jeng, Jen-Chieh Lee, Hung-Han Hsu, Ching-Yao Yang. Am J Surg Pathol 2015
59
50

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, Supawat Thongthip, Joanne Bruno, Titia de Lange, Saurav De, John H J Petrini, Patricia A Sung, Maria Jasin,[...]. PLoS Genet 2012
382
41

Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression.
Aurora Costa, Maria Grazia Daidone, Laura Daprai, Raffaella Villa, Sabrina Cantù, Silvana Pilotti, Luigi Mariani, Alessandro Gronchi, Jeremy D Henson, Roger R Reddel,[...]. Cancer Res 2006
101
41

Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.
Jau-Yu Liau, Jen-Chieh Lee, Jia-Huei Tsai, Ching-Yao Yang, Tsung-Lin Liu, Zhi-Long Ke, Hung-Han Hsu, Yung-Ming Jeng. Mod Pathol 2015
43
41


A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Jeremy D Henson, Jonathan A Hannay, Stanley W McCarthy, Janice A Royds, Thomas R Yeager, Robert A Robinson, Stephen B Wharton, David A Jellinek, Susan M Arbuckle, Jinyoung Yoo,[...]. Clin Cancer Res 2005
210
35

Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
Rachel Litman Flynn, Kelli E Cox, Maya Jeitany, Hiroaki Wakimoto, Alysia R Bryll, Neil J Ganem, Francesca Bersani, Jose R Pineda, Mario L Suvà, Cyril H Benes,[...]. Science 2015
289
35

Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
617
35

Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
Jau-Yu Liau, Jia-Huei Tsai, Ching-Yao Yang, Jen-Chieh Lee, Cher-Wei Liang, Hung-Han Hsu, Yung-Ming Jeng. Hum Pathol 2015
36
35

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
32


Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.
David Clynes, Clare Jelinska, Barbara Xella, Helena Ayyub, Caroline Scott, Matthew Mitson, Stephen Taylor, Douglas R Higgs, Richard J Gibbons. Nat Commun 2015
158
29

ATRX represses alternative lengthening of telomeres.
Christine E Napier, Lily I Huschtscha, Adam Harvey, Kylie Bower, Jane R Noble, Eric A Hendrickson, Roger R Reddel. Oncotarget 2015
95
26

Telomere maintenance by recombination in human cells.
M A Dunham, A A Neumann, C L Fasching, R R Reddel. Nat Genet 2000
661
26

Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
T R Yeager, A A Neumann, A Englezou, L I Huschtscha, J R Noble, R R Reddel. Cancer Res 1999
512
26

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
938
26


TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
Christian Koelsche, Marcus Renner, Wolfgang Hartmann, Regine Brandt, Burkhard Lehner, Nina Waldburger, Ingo Alldinger, Thomas Schmitt, Gerlinde Egerer, Roland Penzel,[...]. J Exp Clin Cancer Res 2014
58
23

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
Yuchen Jiao, Chanjuan Shi, Barish H Edil, Roeland F de Wilde, David S Klimstra, Anirban Maitra, Richard D Schulick, Laura H Tang, Christopher L Wolfgang, Michael A Choti,[...]. Science 2011
23


Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis.
Lorenza Venturini, Rosita Motta, Alessandro Gronchi, MariaGrazia Daidone, Nadia Zaffaroni. BMC Cancer 2010
28
28

Multiple mechanisms of telomere maintenance exist in liposarcomas.
Jay E Johnson, Robert J Varkonyi, Jaclyn Schwalm, Ryan Cragle, Andres Klein-Szanto, Arthur Patchefsky, Edna Cukierman, Margaret von Mehren, Dominique Broccoli. Clin Cancer Res 2005
52
23

Telomerase expression predicts unfavorable outcome in osteosarcoma.
Robert P Sanders, Rachid Drissi, Catherine A Billups, Najat C Daw, Marcus B Valentine, Jeffrey S Dome. J Clin Oncol 2004
74
23

DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Ying Cao, Lily I Huschtscha, Andy C Chang, Amy Y M Au, Hilda A Pickett, Roger R Reddel. Nat Biotechnol 2009
296
23

Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Jennie N Jeyapalan, Aaron Mendez-Bermudez, Nadia Zaffaroni, Yuri E Dubrova, Nicola J Royle. Int J Cancer 2008
43
23

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
Xiang Chen, Armita Bahrami, Alberto Pappo, John Easton, James Dalton, Erin Hedlund, David Ellison, Sheila Shurtleff, Gang Wu, Lei Wei,[...]. Cell Rep 2014
411
20

Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Gary A Ulaner, Andrew R Hoffman, Jesse Otero, Hsuan-Ying Huang, Zhiquan Zhao, Madhu Mazumdar, Richard Gorlick, Paul Meyers, John H Healey, Marc Ladanyi. Genes Chromosomes Cancer 2004
70
20

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations.
Xiao-Yang Liu, Noha Gerges, Andrey Korshunov, Nesrin Sabha, Dong-Anh Khuong-Quang, Adam M Fontebasso, Adam Fleming, Djihad Hadjadj, Jeremy Schwartzentruber, Jacek Majewski,[...]. Acta Neuropathol 2012
274
20

Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically.
Elizabeth Montgomery, Pedram Argani, Jessica L Hicks, Angelo M DeMarzo, Alan K Meeker. Am J Pathol 2004
71
20

Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.
Kasthuri Kannan, Akiko Inagaki, Joachim Silber, Daniel Gorovets, Jianan Zhang, Edward R Kastenhuber, Adriana Heguy, John H Petrini, Timothy A Chan, Jason T Huse. Oncotarget 2012
185
20

Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Toshihiro Matsuo, Jerry W Shay, Woodring E Wright, Eiso Hiyama, Shoji Shimose, Tadahiko Kubo, Takashi Sugita, Yuji Yasunaga, Mitsuo Ochi. J Bone Joint Surg Am 2009
23
30

Association of age at diagnosis and genetic mutations in patients with neuroblastoma.
Nai-Kong V Cheung, Jinghui Zhang, Charles Lu, Matthew Parker, Armita Bahrami, Satish K Tickoo, Adriana Heguy, Alberto S Pappo, Sara Federico, James Dalton,[...]. JAMA 2012
272
20

Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Gary A Ulaner, Hsuan-Ying Huang, Jesse Otero, Zhiquan Zhao, Leah Ben-Porat, Jaya M Satagopan, Richard Gorlick, Paul Meyers, John H Healey, Andrew G Huvos,[...]. Cancer Res 2003
136
20

Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1.
Roderick J O'Sullivan, Nausica Arnoult, Daniel H Lackner, Liana Oganesian, Candy Haggblom, Armelle Corpet, Genevieve Almouzni, Jan Karlseder. Nat Struct Mol Biol 2014
164
20

Telomere elongation in immortal human cells without detectable telomerase activity.
T M Bryan, A Englezou, J Gupta, S Bacchetti, R R Reddel. EMBO J 1995
20

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
335
20

Intratumoral diversity of telomere length in individual neuroblastoma tumors.
Annalisa Pezzolo, Angela Pistorio, Claudio Gambini, Riccardo Haupt, Manuela Ferraro, Giovanni Erminio, Bruno De Bernardi, Alberto Garaventa, Vito Pistoia. Oncotarget 2015
32
21

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
20

Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
Joshua Mangerel, Aryeh Price, Pedro Castelo-Branco, Jack Brzezinski, Pawel Buczkowicz, Patricia Rakopoulos, Diana Merino, Berivan Baskin, Jonathan Wasserman, Matthew Mistry,[...]. Acta Neuropathol 2014
27
22

The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.
Malak Abedalthagafi, Joanna J Phillips, Grace E Kim, Sabine Mueller, Daphne A Haas-Kogen, Roxanne E Marshall, Sidney E Croul, Mariarita R Santi, Jing Cheng, Shengmei Zhou,[...]. Mod Pathol 2013
77
17

Distinct factors control histone variant H3.3 localization at specific genomic regions.
Aaron D Goldberg, Laura A Banaszynski, Kyung-Min Noh, Peter W Lewis, Simon J Elsaesser, Sonja Stadler, Scott Dewell, Martin Law, Xingyi Guo, Xuan Li,[...]. Cell 2010
839
17

Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma.
Tania L Slatter, Howard Hsia, Ari Samaranayaka, Peter Sykes, William Bill Clow, Celia J Devenish, Tim Sutton, Janice A Royds, Philip P Ip, Annie N Cheung,[...]. J Pathol Clin Res 2015
22
27


Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.
V Hakin-Smith, D A Jellinek, D Levy, T Carroll, M Teo, W R Timperley, M J McKay, R R Reddel, J A Royds. Lancet 2003
209
17

Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance.
Lorenza Venturini, Maria Grazia Daidone, Rosita Motta, Graziella Cimino-Reale, Stacey F Hoare, Alessandro Gronchi, Marco Folini, William Nicol Keith, Nadia Zaffaroni. Neuro Oncol 2012
18
33

TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients.
Tsuyoshi Saito, Keisuke Akaike, Aiko Kurisaki-Arakawa, Midori Toda-Ishii, Kenta Mukaihara, Yoshiyuki Suehara, Tatsuya Takagi, Kazuo Kaneko, Takashi Yao. Mol Clin Oncol 2016
15
40

Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Ilaria Marinoni, Anja Schmitt Kurrer, Erik Vassella, Matthias Dettmer, Thomas Rudolph, Vanessa Banz, Fabio Hunger, Silvan Pasquinelli, Ernst-Jan Speel, Aurel Perren. Gastroenterology 2014
255
17

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.